PharmaPoint: Non-Small Cell Lung Cancer – Japan Drug Forecast and Market … – SBWire (press release)

by lowes1 on October 4, 2013

PharmaPoint: Non-Small Cell Lung Cancer – Japan Drug Forecast and Market
SBWire (press release)
Boston, MA — (SBWIRE) — 10/03/2013 — Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However 
PharmaPoint: Non-Small Cell Lung Cancer – US Drug Forecast and Market PR Web (press release)

all 3 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: